Añez, G, Torrente-Segarra, V, Bonet, M, Vilella, MC, Orpinell, L, Fernández, AP, Busquets-Pérez, N, Pascual-Pastor, M, Corominas, H, Diaz-Torne, C, Moya, P, De Agustin, JJ. Clinical and ultrasound optimization in rheumatoid arthritis for patients in sustained remission, can it work as a new optimization tool?. Journal Of Ultrasound. 2025; 28(1)DOI:10.1007/s40477-024-00963-z. PMID:39424691. IF:(Q/D).

Piedra, A, Guinart-Cuadra, A, Recio, SM, Mulet, M, Atenza, CZ, Alejandre, J, Beltran, JS, Joaquín, AB, Sullivan, IG, López, JS, Casado, MDI, Aperribay, EA, Paz-Ares, L, Tain, PD, Vega, ALM, Callejo, A, Martos, JLL, Dominguez, M, Vidal, S, Majem, M. Baseline PD-L1 expression in circulating neutrophils predicts immune-related adverse events (irAEs) in patients with extensive-stage small-cell lung cancer from CANTABRICO trial. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

Majem, M, O'Byrne, KJ, Lo Russo, G, Mueller, C, Triebel, F. TACTI-004: A double-blinded, randomized phase III trial in patients with advanced/metastatic non-small cell lung cancer receiving eftilagimod alfa (MHC class II agonist) in combination with pembrolizumab (P) and chemotherapy (C) versus placebo plus P plus C. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

Gillessen, S, Tombal, B, Turco, F, Choudhury, A, Rodriguez-Vida, A, Gallardo, E, Velho, PI, Nolè, F, Cruz, F, Loriot, Y, McDermott, R, Roumeguere, T, Daugaard, G, Yamamura, R, Bompas, E, Maroto, P, Polo, MH, da Trindade, KM, Preto, DD, Skoneczna, I, Lecouvet, F, Coens, C, Fournier, B, Saad, F. Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis. EUROPEAN UROLOGY. 2025; 87(3)DOI:10.1016/j.eururo.2024.11.027. PMID:39827019. IF:25.200(Q1/1D).

Casado, MDI, Aperribay, EA, Campelo, MRG, Blanco, MCM, Tain, PD, Piqueras, MMLB, Vega, ALM, Mateos, LAL, Rodriguez, JMO, Calderon, VG, Majem, M, Hernandez, AS, de la Rosa, CA, Cabellos, RA, Sureda, BM, Baret, M, Martos, JLL, Dominguez, M, Paz-Ares, L. Patient-reported outcomes from CANTABRICO: Durvalumab plus platinum-etoposide in first-line treatment of extensive stage small cell lung cancer. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

Majem, M, Gregorc, V, Lo Russo, G, Maio, M, Salvagni, S, Calderon, VG, Cao, MG, Contreras, SS, Koumarianou, A, Bearz, A, Caro, RB, Viteri, S, Sanmamed, MF, Zagouri, F, Bueno, MTM, Zhang, Y, Shan, Y, Zhu, H, Rosell, R. First-line (1L) fulzerasib plus cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

Casado, MDI, Aperribay, EA, Campelo, MRG, Blanco, CM, Tain, PD, Piqueras, MMLB, Vega, ALM, Mateos, LAL, Rodriguez, JMO, Calderon, VG, Majem, M, Hernandez, AS, de la Rosa, CA, Cabellos, RA, Sureda, BM, Baret, M, Martos, JLL, Dominguez, M, Paz-Ares, L. Long-term survivors with extensive-stage small-cell lung cancer treated with first-line durvalumab plus carboplatin and etoposide: The CANTABRICO trial. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

Rueda-Lara, A, Viñal, D, Martínez-Pérez, D, Alameda-Guijarro, M, Martin-Montalvo, G, Martínez-Recio, S, Peña-Lopez, J, Jiménez-Bou, D, Ruíz-Gutiérrez, I, García-Leal, A, Zwisler-Contreras, P, Ghanem, I, Custodio, AB, Pérez-Wert, P, Gutiérrez-Sainz, L, Palacios, ME, Feliu, J, Rodríguez-Salas, N. Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospital. ONCOLOGIST. 2025; 30(3)DOI:10.1093/oncolo/oyaf027. PMID:40152315. IF:4.200(Q2/3D).

Szafranska, J, Batto, V, Alcaraz, J, Guinart-Cuadra, A, Brujats, A, Fajardo, J, Acin, V, Garcia, H, Casani, L, Villanueva, C, Ferré, M, del Olmo, TV, Tapias, EA. CT-FIRE a Novel Technique in Quantitative Image Analysis of Collagen Fibers in Chronic Liver Disease Regression Animal Model. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103704. PMID:. IF:4.200(Q1/1D).

Kelley, J, Hissong, E, Szafranska, J, Qin, LH, Lamps, L, Jessurun, J. Clinical Significance and Morphologic Characteristics of Non-Amyloid Heavy and Light Chain Deposition Disease in Gastrointestinal Mucosal Biopsy Specimens. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.102849. PMID:. IF:4.200(Q1/1D).

D'Angelo, E, Kingsley, L, Espinosa, I, Cipriani, V, Marotta, A, Nasr, S, Zdravkovic, S, Howitt, B, Prat, J. Digital Spatial Profiling (DSP) Identifies Different Molecular Signatures Between Uterine Atypical Polyps and Adenosarcomas. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103197. PMID:. IF:4.200(Q1/1D).

Khubrani, R, Elyas, N, Hamidi, D, Stephan, L, Fotovati, R, Kommoss, F, Kommoss, F, Domecq, C, Hamel, N, Wang, YM, Huntsman, D, Zamarin, D, Boroujeni, AM, Chapel, D, Soslow, R, Mccluggage, G, Espinosa, I, Foulkes, W, Tessier-Cloutier, B. Methylation Profiling of Small Cell Carcinoma Hypercalcemic Type (SCCOHT) Identifies Three Groups with Distinct Clinical and Morphological Characteristics. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103244. PMID:. IF:4.200(Q1/1D).

Hein, A, Szafranska, J, Jessurun, J, Panarell, N. Histologic and Clinical Features of Esophageal Squamous Dysplasia: A Comparative Analysis of Basaloid, Classic, Differentiated, Spindle Cell, and Verrucous Variants. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.102833. PMID:. IF:4.200(Q1/1D).

Escamilla-Gómez, V, Gutiérrez, VG, Alcalde-Mellado, P, Astibia-Mahillo, B, Chinea-Rodriguez, A, López-Corral, L, Acera-Gómez, M, Ochando, MKT, Borrego, AB, Pinedo, LG, Ripa, TZ, Vicent, MG, Benzaquén, A, García, II, Cantó, PA, Montoro, J, Martín-Domínguez, FM, Orti, G, Valcárcel, D, Benitez-Carabante, MI, Diaz-de-Heredia, C, Cañamero, E, Ferrá, C, García-Cadenas, I, Redondo, S, Sisinni, L, Perez-Martínez, A, Mussetti, A, Garcia-Mañó, L, Palomo-Moraleda, MD, González-Sierra, PA, Jurado, M, Perez-Simon, JA. Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC. BONE MARROW TRANSPLANTATION. 2025; 60(3)DOI:10.1038/s41409-024-02483-0. PMID:39663471. IF:5.200(Q1/1D).

Gallego, P, Ambroa, E, Pérezalija, J, Jornet, N, Anson, C, Tejedor, N, Vivancos, H, Ruiz, A, Barceló, M, Dominguez, A., Riu, V, Roda, J, Carrasco, P, Balocco, S, Díaz, O. Breast radiotherapy planning: A decision-making framework using deep learning. MEDICAL PHYSICS. 2025; 52(3)DOI:10.1002/mp.17527. PMID:39625151. IF:3.200(Q1/3D).

Santos García D, Pagonabarraga Mora J, Escamilla Sevilla F, García Ruiz PJ, Infante Ceberio J, Kulisevsky Bojarski J, Linazasoro Cristóbal G, Luquín Piudo MR, Martínez Castrillo JC, Jesús Maestre S, Vela Desojo L, Campos Lucas FJ, Caballero Martínez F, Mir P. Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.. Neurologia. 2025; 40(2)DOI:10.1016/j.nrleng.2023.04.008. PMID:37419211. IF:(Q/D).

Sumarroca, A, Vega, C, López, S, Leidinger, A, Pedemonte, G, León, X, Costa-González, JM. Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results. Acta Otorrinolaringologica Espanola. 2025; 76(2)DOI:10.1016/j.otorri.2024.10.001. PMID:39923991. IF:(Q/D).

Wiels, WA, Oomens, JE, Engelborghs, S, Baeken, C, von Arnim, CAF, Boada, M, Didic, M, Dubois, B, Fladby, T, van der Flier, WM, Frisoni, GB, Froehlich, L, Gill, KD, Grimmer, T, Hildebrandt, H, Hort, J, Itoh, Y, Iwatsubo, T, Klimkowicz-Mrowiec, A, Lee, DY, Lleo, A, Martinez-Lage, P, de Mendonca, A, Meyer, PT, Kapaki, EN, Parchi, P, Pardini, M, Parnetti, L, Popp, J, Rami, L, Reiman, EM, Rinne, JO, Rodrigue, KM, Sanchez-Juan, P, Santana, I, Sarazin, M, Scarmeas, N, Skoog, I, Snyder, PJ, Sperling, RA, Villeneuve, S, Wallin, A, Wiltfang, J, Zetterberg, H, Ossenkoppele, R, Verhey, FRJ, Vos, SJB, Visser, PJ, Jansen, WJ. Depressive Symptoms and Amyloid Pathology. JAMA Psychiatry. 2025; 82(3)DOI:10.1001/jamapsychiatry.2024.4305. PMID:39841452. IF:17.100(Q1/1D).

Fraga Rodríguez GM, Devolder Nicolau, A. Poliquistosis renal autosómica dominante: riesgo de progresión y perspectivas de tratamiento en edad pediátrica. Anales de Nefrología Pediátrica. 2025; 1(10)DOI:. PMID:. IF:(Q/D).

Majoie M, Visser A, Ulubas M, van Mastrigt G, Alonso-Coello P, Valli C, Niño de Guzman E, Gartlehner G, Nussbaumer-Streit B, Klerings I, James R, Service D, Evers S, Kleijnen J, Leone M, Verstegen D. Curriculum Innovations: Teaching Residents About Guideline Development and Cost-Conscious Care: A Mixed-Method Evaluation Study.. Neurology. Education. 2025; 4(1)DOI:10.1212/NE9.0000000000200198. PMID:40041757. IF:(Q/D).